Kringle Pharma, Inc. 4884.T Stock
Kringle Pharma, Inc. Price Chart
Kringle Pharma, Inc. 4884.T Financial and Trading Overview
| Kringle Pharma, Inc. stock price | 597 JPY |
| Previous Close | 838 JPY |
| Open | 836 JPY |
| Bid | 853 JPY x N/A |
| Ask | 862 JPY x N/A |
| Day's Range | 833 - 864 JPY |
| 52 Week Range | 419 - 1404 JPY |
| Volume | 71K JPY |
| Avg. Volume | 252.91K JPY |
| Market Cap | 4.61B JPY |
| Beta (5Y Monthly) | 0.378835 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -158.63 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4884.T Valuation Measures
| Enterprise Value | 2.17B JPY |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.593875 |
| Price/Book (mrq) | 1.8613836 |
| Enterprise Value/Revenue | 5.443 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Kringle Pharma, Inc. Stock Price History
| Beta (5Y Monthly) | 0.378835 |
| 52-Week Change | 39.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1404 JPY |
| 52 Week Low | 419 JPY |
| 50-Day Moving Average | 893.72 JPY |
| 200-Day Moving Average | 713.38 JPY |
4884.T Share Statistics
| Avg. Volume (3 month) | 252.91K JPY |
| Avg. Daily Volume (10-Days) | 70.62K JPY |
| Shares Outstanding | 5.39M |
| Float | 3.49M |
| Short Ratio | N/A |
| % Held by Insiders | 27.35% |
| % Held by Institutions | 10.63% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | -82.16% |
| Operating Margin (ttm) | -108.040% |
| Gross Margin | 77.88% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -9.29% |
| Return on Equity (ttm) | -12.92% |
Income Statement
| Revenue (ttm) | 398M JPY |
| Revenue Per Share (ttm) | 75.51 JPY |
| Quarterly Revenue Growth (yoy) | 21.39% |
| Gross Profit (ttm) | 303M JPY |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -327000000 JPY |
| Diluted EPS (ttm) | -54.27 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.46B JPY |
| Total Cash Per Share (mrq) | 457.64 JPY |
| Total Debt (mrq) | 0 JPY |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 21.418 |
| Book Value Per Share (mrq) | 459.873 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -129000000 JPY |
| Levered Free Cash Flow (ttm) | -331750016 JPY |
Profile of Kringle Pharma, Inc.
| Country | Japan |
| State | N/A |
| City | Ibaraki |
| Address | 207 Saito Bio Incubator |
| ZIP | 567-0085 |
| Phone | 81 7 2641 8739 |
| Website | https://www.kringle-pharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Kringle Pharma, Inc. engages in the research and development of hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, acute kidney injury, and vocal fold scar. Kringle Pharma, Inc. was incorporated in 2001 and is based in Ibaraki, Japan.
Q&A For Kringle Pharma, Inc. Stock
What is a current 4884.T stock price?
Kringle Pharma, Inc. 4884.T stock price today per share is 597 JPY.
How to purchase Kringle Pharma, Inc. stock?
You can buy 4884.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kringle Pharma, Inc.?
The stock symbol or ticker of Kringle Pharma, Inc. is 4884.T.
Which industry does the Kringle Pharma, Inc. company belong to?
The Kringle Pharma, Inc. industry is Biotechnology.
How many shares does Kringle Pharma, Inc. have in circulation?
The max supply of Kringle Pharma, Inc. shares is 6.47M.
What is Kringle Pharma, Inc. Price to Earnings Ratio (PE Ratio)?
Kringle Pharma, Inc. PE Ratio is now.
What was Kringle Pharma, Inc. earnings per share over the trailing 12 months (TTM)?
Kringle Pharma, Inc. EPS is -158.63 JPY over the trailing 12 months.
Which sector does the Kringle Pharma, Inc. company belong to?
The Kringle Pharma, Inc. sector is Healthcare.